O’Melveny Represents Sole Sponsor and Underwriters in IPO of Qyuns Therapeutics, First for an 18A Company in 2024
March 20, 2024
FOR IMMEDIATE RELEASE
HONG KONG—March 20, 2024— O’Melveny recently represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the initial public offering and listing of Qyuns Therapeutics Co., Ltd. (2509.HK) on the Main Board of the Hong Kong Stock Exchange. The offering size was approximately HK$238.5 million (approximately US$31 million).
Founded in 2015, Qyuns focuses on the development of clinical-stage biologic antibody drugs for autoimmune and allergic diseases. It has built a comprehensive pipeline covering the four major disease areas in the field, namely, skin, rheumatic, respiratory and digestive diseases.
This is the first listing of a Chapter 18A company in 2024, and O’Melveny’s 16th Hong Kong IPO completed for Chapter 18A biotech companies, further solidifying the firm’s leading position in this field.
The team was led by partners Ke Geng and Ke Zhu. The core team members included counsel Qianyu Hu and Katherine Wang, associates Wuxiao Liang, Jingwei Huang and Jeffery Hang, trainee solicitor Ella Li, paralegal Aileen Xu, and legal consultant Nick Mu. Associate Cherry Ma also provided valuable support.
About O’Melveny
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com; read our Insights 2024 report; learn more in our firm at-a-glance; and find us on LinkedIn, X, Facebook, Instagram, and YouTube.
Contact:
Brandon Jacobsen
O’Melveny & Myers LLP
+1 213 430 8024
bjacobsen@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com
# # #